The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Bronchopulmonary Dysplasia

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Bronchopulmonary Dysplasia


Psychiatry related information on Bronchopulmonary Dysplasia


High impact information on Bronchopulmonary Dysplasia


Chemical compound and disease context of Bronchopulmonary Dysplasia


Biological context of Bronchopulmonary Dysplasia


Anatomical context of Bronchopulmonary Dysplasia


Gene context of Bronchopulmonary Dysplasia


Analytical, diagnostic and therapeutic context of Bronchopulmonary Dysplasia


  1. Late pulmonary sequelae of bronchopulmonary dysplasia. Northway, W.H., Moss, R.B., Carlisle, K.B., Parker, B.R., Popp, R.L., Pitlick, P.T., Eichler, I., Lamm, R.L., Brown, B.W. N. Engl. J. Med. (1990) [Pubmed]
  2. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Merritt, T.A., Cochrane, C.G., Holcomb, K., Bohl, B., Hallman, M., Strayer, D., Edwards, D.K., Gluck, L. J. Clin. Invest. (1983) [Pubmed]
  3. Clinical uses and abuses of vitamin E in children. Mino, M. Proc. Soc. Exp. Biol. Med. (1992) [Pubmed]
  4. Improved outcome at 28 days of age for very low birth weight infants treated with a single dose of a synthetic surfactant. Bose, C., Corbet, A., Bose, G., Garcia-Prats, J., Lombardy, L., Wold, D., Donlon, D., Long, W. J. Pediatr. (1990) [Pubmed]
  5. Secretory leukocyte protease inhibitor and lung inflammation in developing bronchopulmonary dysplasia. Watterberg, K.L., Carmichael, D.F., Gerdes, J.S., Werner, S., Backstrom, C., Murphy, S. J. Pediatr. (1994) [Pubmed]
  6. Effect of position and support on oral-motor skills of a child with bronchopulmonary dysplasia. Kerwin, M.E., Osborne, M., Eicher, P.S. Clinical pediatrics. (1994) [Pubmed]
  7. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. Cole, C.H., Colton, T., Shah, B.L., Abbasi, S., MacKinnon, B.L., Demissie, S., Frantz, I.D. N. Engl. J. Med. (1999) [Pubmed]
  8. Inositol supplementation in premature infants with respiratory distress syndrome. Hallman, M., Bry, K., Hoppu, K., Lappi, M., Pohjavuori, M. N. Engl. J. Med. (1992) [Pubmed]
  9. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. Cummings, J.J., D'Eugenio, D.B., Gross, S.J. N. Engl. J. Med. (1989) [Pubmed]
  10. Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report. Ehrenkranz, R.A., Bonta, B.W., Ablow, R.C., Warshaw, J.B. N. Engl. J. Med. (1978) [Pubmed]
  11. Use of anticholinergic bronchodilation in children. Rubin, B.K., Albers, G.M. Am. J. Med. (1996) [Pubmed]
  12. Effect of vitamin A supplementation of intravenous lipids on early vitamin A intake and status of premature infants. Werkman, S.H., Peeples, J.M., Cooke, R.J., Tolley, E.A., Carlson, S.E. Am. J. Clin. Nutr. (1994) [Pubmed]
  13. Surfactant protein-A deficiency in a primate model of bronchopulmonary dysplasia. King, R.J., Coalson, J.J., deLemos, R.A., Gerstmann, D.R., Seidner, S.R. Am. J. Respir. Crit. Care Med. (1995) [Pubmed]
  14. Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia. Viscardi, R.M., Hasday, J.D., Gumpper, K.F., Taciak, V., Campbell, A.B., Palmer, T.W. Am. J. Respir. Crit. Care Med. (1997) [Pubmed]
  15. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Altiok, O., Yasumatsu, R., Bingol-Karakoc, G., Riese, R.J., Stahlman, M.T., Dwyer, W., Pierce, R.A., Bromme, D., Weber, E., Cataltepe, S. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  16. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Sanders, R.J., Cox, C., Phelps, D.L., Sinkin, R.A. Pediatr. Res. (1994) [Pubmed]
  17. Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia. Kirpalani, H., Koren, G., Schmidt, B., Tan, Y., Santos, R., Soldin, S. Crit. Care Med. (1990) [Pubmed]
  18. Adrenal function in premature infants during inhaled beclomethasone therapy. Cole, C.H., Shah, B., Abbasi, S., Demissie, S., MacKinnon, B., Colton, T., Frantz, I.D. J. Pediatr. (1999) [Pubmed]
  19. Effects of intravenous glucose loading on oxygen consumption, carbon dioxide production, and resting energy expenditure in infants with bronchopulmonary dysplasia. Yunis, K.A., Oh, W. J. Pediatr. (1989) [Pubmed]
  20. Alpha-adrenergic bronchoprovocation in neonates with bronchopulmonary dysplasia. Mirmanesh, S.J., Abbasi, S., Bhutani, V.K. J. Pediatr. (1992) [Pubmed]
  21. Urinary excretion of prostaglandin E following the administration of furosemide and indomethacin to sick low-birth-weight infants. Friedman, Z., Demers, L.M., Marks, K.H., Uhrmann, S., Maisels, M.J. J. Pediatr. (1978) [Pubmed]
  22. Role of furosemide therapy after booster-packed erythrocyte transfusions in infants with bronchopulmonary dysplasia. Stefano, J.L., Bhutani, V.K. J. Pediatr. (1990) [Pubmed]
  23. Pulmonary effect of inhaled furosemide in ventilated infants with severe bronchopulmonary dysplasia. Prabhu, V.G. Pediatrics (1997) [Pubmed]
  24. Effects of furosemide on body water compartments in infants with bronchopulmonary dysplasia. O'Donovan, B.H., Bell, E.F. Pediatr. Res. (1989) [Pubmed]
  25. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension. Brownlee, J.R., Beekman, R.H., Rosenthal, A. Pediatr. Res. (1988) [Pubmed]
  26. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Bhatt, A.J., Pryhuber, G.S., Huyck, H., Watkins, R.H., Metlay, L.A., Maniscalco, W.M. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  27. Secretoglobins SCGB3A1 and SCGB3A2 define secretory cell subsets in mouse and human airways. Reynolds, S.D., Reynolds, P.R., Pryhuber, G.S., Finder, J.D., Stripp, B.R. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  28. Endothelin-1 has a priming effect on production of superoxide anion by alveolar macrophages: its possible correlation with bronchopulmonary dysplasia. Kojima, T., Hattori, K., Hirata, Y., Aoki, T., Sasai-Takedatsu, M., Kino, M., Kobayashi, Y. Pediatr. Res. (1996) [Pubmed]
  29. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Tang, J.R., Markham, N.E., Lin, Y.J., McMurtry, I.F., Maxey, A., Kinsella, J.P., Abman, S.H. Am. J. Physiol. Lung Cell Mol. Physiol. (2004) [Pubmed]
  30. Interleukin-10 inhibits proinflammatory chemokine release by neutrophils of the newborn without suppression of nuclear factor-kappa B. Tryzmel, J., Miskolci, V., Castro-Alcaraz, S., Vancurova, I., Davidson, D. Pediatr. Res. (2003) [Pubmed]
  31. Tracheal lavage and plasma fibronectin: relationship to respiratory distress syndrome and development of bronchopulmonary dysplasia. Gerdes, J.S., Yoder, M.C., Douglas, S.D., Paul, M., Harris, M.C., Polin, R.A. J. Pediatr. (1986) [Pubmed]
  32. Early dexamethasone-attempting to prevent chronic lung disease. Sinkin, R.A., Dweck, H.S., Horgan, M.J., Gallaher, K.J., Cox, C., Maniscalco, W.M., Chess, P.R., D'Angio, C.T., Guillet, R., Kendig, J.W., Ryan, R.M., Phelps, D.L. Pediatrics (2000) [Pubmed]
  33. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Avery, G.B., Fletcher, A.B., Kaplan, M., Brudno, D.S. Pediatrics (1985) [Pubmed]
  34. Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia. Rotschild, A., Solimano, A., Puterman, M., Smyth, J., Sharma, A., Albersheim, S. J. Pediatr. (1989) [Pubmed]
  35. Passive compliance of total respiratory system in preterm newborn infants with respiratory distress syndrome. Dreizzen, E., Migdal, M., Praud, J.P., Magny, J.F., Dehan, M., Chambille, B., Gaultier, C. J. Pediatr. (1988) [Pubmed]
WikiGenes - Universities